Ovid Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference
September 09 2019 - 8:00AM
Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company
committed to developing medicines that transform the lives of
people with rare neurological diseases, today announced that
Jeremey Levin, DPhil, MB, BChir, Chairman and Chief Executive
Officer, will present a corporate overview at the H.C. Wainwright
21st Annual Global Investment Conference on Tuesday, September 10,
2019 at 9:30 a.m. EDT. In addition, Dr. Levin will give a keynote
address entitled “The State of the Biotechnology Sector Going into
an Election Year” on Tuesday, September 10, at 1:00 p.m. EDT. The
conference will be held at the Lotte New York Palace Hotel in New
York City.
A live audio webcast of the presentation can be
accessed through the Events & Presentations section of the
company's website at investors.ovidrx.com. An archived replay
of the webcast will be available on the company's website for two
weeks following the live presentation.
About Ovid TherapeuticsOvid Therapeutics Inc.
is a New York-based biopharmaceutical company using its
BoldMedicine® approach to develop medicines that transform the
lives of patients with rare neurological disorders. Ovid has a
broad pipeline of potential first-in-class medicines. The company’s
most advanced investigational medicine, OV101 (gaboxadol), is
currently in clinical development for the treatment of Angelman
syndrome and Fragile X syndrome. Ovid is also developing OV935
(soticlestat) in collaboration with Takeda Pharmaceutical Company
Limited for the potential treatment of rare developmental and
epileptic encephalopathies (DEE).
For more information on Ovid, please visit
http://www.ovidrx.com/.
Contacts
Investors and Media:Ovid Therapeutics
Inc.Investor Relations & Public Relationsirpr@ovidrx.com
Or
Investors: Steve KlassBurns McClellan,
Inc.sklass@burnsmc.com (212) 213-0006
Media: Katie Engleman1ABkatie@1abmedia.com
(919) 333-7722
Ovid Therapeutics (NASDAQ:OVID)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ovid Therapeutics (NASDAQ:OVID)
Historical Stock Chart
From Apr 2023 to Apr 2024